Development of lecithinized superoxide dismutase as a drug for IPF

Tohru Mizushima

Research output: Contribution to journalArticle

Abstract

Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are thought to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing the clinical study of PC-SOD for IPF patients.

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalDrug Delivery System
Volume28
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Idiopathic Pulmonary Fibrosis
Superoxide Dismutase
Pharmaceutical Preparations
Superoxides
Chronic Obstructive Pulmonary Disease
Lung Injury
Hydrogen Peroxide
Reactive Oxygen Species
lecithinized superoxide dismutase
Enzymes

Keywords

  • Chronic obstructive pulmonary disease
  • Idiopathic pulmonary fibrosis
  • Lecithinized SOD
  • Reactive oxygen species
  • Superoxide dismutase

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Development of lecithinized superoxide dismutase as a drug for IPF. / Mizushima, Tohru.

In: Drug Delivery System, Vol. 28, No. 3, 2013, p. 221-228.

Research output: Contribution to journalArticle

Mizushima, Tohru. / Development of lecithinized superoxide dismutase as a drug for IPF. In: Drug Delivery System. 2013 ; Vol. 28, No. 3. pp. 221-228.
@article{546f2ce217f74fb4ade49944f555c32e,
title = "Development of lecithinized superoxide dismutase as a drug for IPF",
abstract = "Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are thought to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing the clinical study of PC-SOD for IPF patients.",
keywords = "Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Lecithinized SOD, Reactive oxygen species, Superoxide dismutase",
author = "Tohru Mizushima",
year = "2013",
doi = "10.2745/dds.28.221",
language = "English",
volume = "28",
pages = "221--228",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "3",

}

TY - JOUR

T1 - Development of lecithinized superoxide dismutase as a drug for IPF

AU - Mizushima, Tohru

PY - 2013

Y1 - 2013

N2 - Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are thought to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing the clinical study of PC-SOD for IPF patients.

AB - Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are thought to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing the clinical study of PC-SOD for IPF patients.

KW - Chronic obstructive pulmonary disease

KW - Idiopathic pulmonary fibrosis

KW - Lecithinized SOD

KW - Reactive oxygen species

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=84940356214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940356214&partnerID=8YFLogxK

U2 - 10.2745/dds.28.221

DO - 10.2745/dds.28.221

M3 - Article

AN - SCOPUS:84940356214

VL - 28

SP - 221

EP - 228

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 3

ER -